MENU
+Compare
HAE
Stock ticker: NYSE
AS OF
Aug 14, 04:59 PM (EDT)
Price
$52.33
Change
-$1.55 (-2.88%)
Capitalization
2.52B

HAE Haemonetics Corp Forecast, Technical & Fundamental Analysis

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces... Show more

HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HAE with price predictions
Aug 13, 2025

HAE in downward trend: 10-day moving average crossed below 50-day moving average on August 08, 2025

The 10-day moving average for HAE crossed bearishly below the 50-day moving average on August 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HAE as a result. In of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HAE turned negative on July 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

HAE moved below its 50-day moving average on August 07, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HAE entered a downward trend on August 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for HAE moved above the 200-day moving average on July 24, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HAE advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

HAE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.857) is normal, around the industry mean (59.557). P/E Ratio (16.003) is within average values for comparable stocks, (39.199). Projected Growth (PEG Ratio) (0.895) is also within normal values, averaging (1.703). HAE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (1.941) is also within normal values, averaging (94.608).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HAE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
HAE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

HAE is expected to report earnings to rise 2.73% to $1.13 per share on November 05

Haemonetics Corp HAE Stock Earnings Reports
Q3'25
Est.
$1.13
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.05
The last earnings report on August 07 showed earnings per share of $1.10, beating the estimate of $1.01. With 1.40M shares outstanding, the current market capitalization sits at 2.52B.
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AHSCX11.57N/A
N/A
Alger Health Sciences C
PTSGX18.73N/A
N/A
Touchstone Sands Capital Select Growth Z
TIBIX31.68N/A
N/A
Thornburg Investment Income Builder I
FSKGX20.57N/A
N/A
Fidelity Growth Strategies K6
JSJAX16.74N/A
N/A
JHancock Small Cap Dynamic Growth A

HAE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with MXCT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then MXCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-2.88%
MXCT - HAE
46%
Loosely correlated
+2.17%
ATR - HAE
41%
Loosely correlated
-2.18%
GH - HAE
39%
Loosely correlated
+3.06%
CERS - HAE
38%
Loosely correlated
-4.51%
VREX - HAE
37%
Loosely correlated
+0.84%
More

Groups containing HAE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-2.88%
Medical/Nursing Services
industry (226 stocks)
27%
Poorly correlated
-0.42%
Health Services
industry (440 stocks)
23%
Poorly correlated
-0.53%